Aspirin and the risk of colorectal cancer in women.

Aspirin use and survival after diagnosis of colorectal cancer. JAMA (2009) 6.93

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet (2011) 6.77

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci U S A (1997) 4.84

Comparison of risk factors for colon and rectal cancer. Int J Cancer (2004) 4.03

Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut (2010) 4.01

Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA (2005) 3.88

Aspirin as prophylaxis against colorectal cancer. N Engl J Med (1995) 3.83

Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. BMJ (2000) 3.10

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest (1997) 2.99

Aspirin dose and duration of use and risk of colorectal cancer in men. Gastroenterology (2007) 2.73

Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer (2003) 2.43

gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc Natl Acad Sci U S A (2000) 2.29

Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer (2001) 2.26

Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc Natl Acad Sci U S A (1999) 2.21

Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Proc Natl Acad Sci U S A (1997) 2.12

Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis. BMC Cancer (2003) 1.98

Generating hypotheses by discovering implicit associations in the literature: a case report of a search for new potential therapeutic uses for thalidomide. J Am Med Inform Assoc (2003) 1.97

Individualizing colonoscopy screening by sex and race. Gastrointest Endosc (2009) 1.96

Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc Natl Acad Sci U S A (1996) 1.88

A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin. Br J Cancer (2003) 1.88

Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence. J Clin Oncol (2012) 1.85

Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing. Br J Cancer (1999) 1.85

Combined analysis of COX-2 and p53 expressions reveals synergistic inverse correlations with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Neoplasia (2006) 1.84

Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy. Br J Pharmacol (1999) 1.65

A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis. Cancer Prev Res (Phila) (2011) 1.64

Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation. Proc Natl Acad Sci U S A (1997) 1.64

Aspirin use, 8q24 single nucleotide polymorphism rs6983267, and colorectal cancer according to CTNNB1 alterations. J Natl Cancer Inst (2013) 1.63

Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene. Proc Natl Acad Sci U S A (2003) 1.56

Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation. Mol Med (1996) 1.55

Use of aspirin postdiagnosis improves survival for colon cancer patients. Br J Cancer (2012) 1.54

Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1. J Clin Invest (1997) 1.54

Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage. Proc Natl Acad Sci U S A (2006) 1.48

Non-steroidal anti-inflammatory drugs and bladder cancer prevention. Br J Cancer (2000) 1.46

Colorectal cancer screening and prevention in women. Dig Dis Sci (2015) 1.46

Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort. Am J Gastroenterol (2011) 1.34

Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer. Br J Cancer (2000) 1.31

Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation. Biochem J (1996) 1.30

Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling. J Clin Invest (1996) 1.27

Aspirin as adjuvant therapy for colorectal cancer--reinterpreting paradigms. Nat Rev Clin Oncol (2012) 1.26

Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancer. Cancer Res (2008) 1.25

Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522. Br J Cancer (1999) 1.25

Aspirin use and potential mechanisms for colorectal cancer prevention. J Clin Invest (1997) 1.25

Regular use of analgesics is a risk factor for renal cell carcinoma. Br J Cancer (1999) 1.23

The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models. J Gastroenterol (2012) 1.20

Inhibition of 11beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans. J Clin Invest (2009) 1.14

Do nonsteroidal anti-inflammatory drugs affect the risk of developing ovarian cancer? A meta-analysis. Br J Clin Pharmacol (2005) 1.13

Expression of COX-2, NF-kappaB-p65, NF-kappaB-p50 and IKKalpha in malignant and adjacent normal human colorectal tissue. Br J Cancer (2009) 1.08

Tissue prostanoids as biomarkers for chemoprevention of colorectal neoplasia: correlation between prostanoid synthesis and clinical response in familial adenomatous polyposis. Prostaglandins Other Lipid Mediat (2000) 1.08

Cyclooxygenase-2 and its role in colorectal cancer development. Virchows Arch (2004) 1.07

Carcinogenesis and chemoprevention of biliary tract cancer in pancreaticobiliary maljunction. World J Gastrointest Oncol (2010) 1.06

Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study. J Natl Cancer Inst (2009) 1.05

Use of nonsteroidal antiinflammatory agents and incidence of ovarian cancer in 2 large prospective cohorts. Am J Epidemiol (2009) 1.05

COX-2 and cancer: a new approach to an old problem. Br J Pharmacol (2001) 1.02

Aspirin use and cancers of the upper aerodigestive tract. Br J Cancer (2003) 1.02

Dose-risk and duration-risk relationships between aspirin and colorectal cancer: a meta-analysis of published cohort studies. PLoS One (2013) 1.01

Adipocytes: impact on tumor growth and potential sites for therapeutic intervention. Pharmacol Ther (2013) 1.00

Cyclooxygenase-2 is involved in the up-regulation of matrix metalloproteinase-9 in cholangiocarcinoma induced by tumor necrosis factor-alpha. Am J Pathol (2009) 1.00

Monocyte chemoattractant protein 1 and macrophage cyclooxygenase 2 expression in colonic adenoma. Gut (2005) 1.00

Non-steroidol anti-inflammatory drug effect on crypt cell proliferation and apoptosis during initiation of rat colon carcinogenesis. Br J Cancer (1998) 0.98

Posttranscriptional regulation of cyclooxygenase-2 in rat intestinal epithelial cells. Neoplasia (2001) 0.98

Aspirin induces apoptosis through release of cytochrome c from mitochondria. Neoplasia (2001) 0.97

Transgenic expression of cyclooxygenase-2 in mouse intestine epithelium is insufficient to initiate tumorigenesis but promotes tumor progression. Cancer Lett (2008) 0.97

Myofibroblasts: paracrine cells important in health and disease. Trans Am Clin Climatol Assoc (2000) 0.97

Molecular pathways: aspirin and Wnt signaling-a molecularly targeted approach to cancer prevention and treatment. Clin Cancer Res (2014) 0.96

Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma. Br J Cancer (2005) 0.96

Transdisciplinary training in cancer prevention: reflections on two decades of training. J Cancer Educ (2011) 0.96

Cyclooxygenase-2 expression in Barrett's esophagus. Dig Dis Sci (2001) 0.96

Role of Helicobacter pylori eradication in aspirin or non-steroidal anti-inflammatory drug users. World J Gastroenterol (2005) 0.95

Aspirin and colorectal cancer. Br J Cancer (1997) 0.94

The role of chemotherapy in microsatellite unstable (MSI-H) colorectal cancer. Int J Colorectal Dis (2006) 0.94

Clinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor gamma in epithelial ovarian tumours. Br J Cancer (2004) 0.93

Cyclooxygenase-2 overexpression is common in serrated and non-serrated colorectal adenoma, but uncommon in hyperplastic polyp and sessile serrated polyp/adenoma. BMC Cancer (2008) 0.93

A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer. Breast Cancer Res (2013) 0.92

Cumulative ultraviolet radiation flux in adulthood and risk of incident skin cancers in women. Br J Cancer (2014) 0.92

Inhibition of beta-catenin translocation in rodent colorectal tumors: a novel explanation for the protective effect of nonsteroidal antiinflammatory drugs in colorectal cancer. Dig Dis Sci (2001) 0.91

Tolfenamic acid induces apoptosis and growth inhibition in head and neck cancer: involvement of NAG-1 expression. PLoS One (2012) 0.90

The role of PGE2-associated inflammatory responses in gastric cancer development. Semin Immunopathol (2012) 0.90

Perils of immunohistochemistry: variability in staining specificity of commercially available COX-2 antibodies on human colon tissue. Dig Dis Sci (2003) 0.89

Nimesulide inhibits proliferation via induction of apoptosis and cell cycle arrest in human gastric adenocarcinoma cell line. World J Gastroenterol (2003) 0.89

The utility of Aspirin in Dukes C and High Risk Dukes B Colorectal cancer--the ASCOLT study: study protocol for a randomized controlled trial. Trials (2011) 0.89

Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells. World J Gastroenterol (2007) 0.89

Chemoprevention of colorectal cancer. Gut (1998) 0.88

CDK/CCN and CDKI alterations for cancer prognosis and therapeutic predictivity. Biomed Res Int (2014) 0.88

Expression and prognostic significance of Cox-2 and p-53 in Hodgkin lymphomas: a retrospective study. Diagn Pathol (2010) 0.88

Comparative efficacy of 5flourouracil/calcium leucovorine versus 5flourouracil/calcium leucovorine plus oxaliplatin in the adjuvant treatment of colonic carcinoma in Kashmir. South Asian J Cancer (2013) 0.88

Clinicopathologic association of cyclooxygenase 1 and cyclooxygenase 2 expression in gastric adenocarcinoma. Ann Surg (2001) 0.88

Regular aspirin use and risk of multiple myeloma: a prospective analysis in the health professionals follow-up study and nurses' health study. Cancer Prev Res (Phila) (2013) 0.87

Folate status and risk of colorectal polyps in African Americans. Dig Dis Sci (2007) 0.87

Apoptosis induced by aspirin and 5-fluorouracil in human colonic adenocarcinoma cells. Dig Dis Sci (2005) 0.87

Aspirin use, body mass index, physical activity, plasma C-peptide, and colon cancer risk in US health professionals. Am J Epidemiol (2011) 0.87

Use of nonsteroidal antiinflammatory drugs and distal large bowel cancer in whites and African Americans. Am J Epidemiol (2008) 0.86

Celecoxib decreases expression of the adhesion molecules ICAM-1 and VCAM-1 in a colon cancer cell line (HT29). Br J Pharmacol (2007) 0.86

Therapeutic utility of aspirin in the ApcMin/+ murine model of colon carcinogenesis. BMC Cancer (2002) 0.86

Aspirin, but not sodium salicylate, indomethacin, or nabumetone, reversibly suppresses 1,2-dimethylhydrazine-induced colonic aberrant crypt foci in rats. Dig Dis Sci (1997) 0.86

Chemoprevention in Lynch syndrome. Fam Cancer (2013) 0.86

Anti-tumor enhancement of Fei-Liu-Ping ointment in combination with celecoxib via cyclooxygenase-2-mediated lung metastatic inflammatory microenvironment in Lewis lung carcinoma xenograft mouse model. J Transl Med (2015) 0.86

Colorectal cancer after start of nonsteroidal anti-inflammatory drug use. Am J Med (2006) 0.86

Risk factors for self-reported colon polyps. J Gen Intern Med (1998) 0.85

Chemoprevention of colorectal cancer in ulcerative colitis. Int J Colorectal Dis (2003) 0.85

Lack of association of miR-146a rs2910164 polymorphism with gastrointestinal cancers: evidence from 10206 subjects. PLoS One (2012) 0.85

An association between air pollution and mortality in six U.S. cities. N Engl J Med (1993) 38.84

Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol (1985) 26.13

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med (1997) 18.85

Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol (1992) 17.17

Total energy intake: implications for epidemiologic analyses. Am J Epidemiol (1986) 16.34

Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am J Respir Crit Care Med (1995) 15.80

Observations on recent increase in mortality from asthma. Br Med J (1968) 14.82

Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med (2001) 14.48

The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med (1995) 11.08

Body weight and mortality among women. N Engl J Med (1995) 11.04

OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage (2008) 10.99

Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol (1989) 10.98

Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol (1986) 10.84

Validity of self-reported waist and hip circumferences in men and women. Epidemiology (1990) 10.57

Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet (1998) 10.11

Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol (1994) 9.90

Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc (1993) 9.90

Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol (1999) 9.34

Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J (1985) 9.28

Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med (2000) 9.05

Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med (1990) 8.98

No hiding place: on the discomforts of researching the contemporary policy process. J Soc Policy (1990) 8.97

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med (1991) 8.66

Prospective study of alcohol consumption and risk of coronary disease in men. Lancet (1991) 8.64

A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA (1995) 8.60

Test of the National Death Index. Am J Epidemiol (1984) 8.46

Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med (1997) 8.43

Misinterpretation and misuse of the kappa statistic. Am J Epidemiol (1987) 8.29

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation (2000) 8.17

Evidence based policymaking. BMJ (1995) 8.08

Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet (1991) 7.87

Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med (1995) 7.62

OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage (2010) 7.52

A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol (1990) 7.24

Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care (1994) 7.11

Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA (1998) 7.09

Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med (2001) 7.07

Guidelines for healthy weight. N Engl J Med (1999) 7.03

Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. Am J Clin Nutr (1999) 7.02

Plasma organochlorine levels and the risk of breast cancer. N Engl J Med (1997) 7.02

Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA (1997) 6.92

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science (1998) 6.50

Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol (1994) 6.47

The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med (2001) 6.37

Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med (1993) 6.37